Back

Manifestations and outcome of severe warfarin overanticoagulation - the EWA study.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters 6 - Best Posters in tailoring anticoagulant therapy Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Samuli Jaakkola

Turku University Hospital, Turku (Finland)

4 More presentations in this session

Presentation thumbnail
Discussant: Best Posters in tailoring anticoagulant therapy
Presentation thumbnail
Direct factor Xa inhibition prevents cardiac remodeling induced by intermittent hypoxia through PAR-1/2 dual signaling pathway.
Miss M. Shimada (Takatsuki, JP)
Abstract
Presentation thumbnail
A patient-specific tailored intervention improves INR time in therapeutic range and INR variability in heart failure patients: A randomized controlled trial
Associate Professor I. Gotsman (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Low TAFI level increases the risk of bleedings in a target INR during long-term warfarin therapy
Doctor N. Vorobyeva (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 6 - Best Posters in tailoring anticoagulant therapy

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources